Diagnostic tools used for melanoma: A survey of Australian general practitioners and dermatologists
- PMID: 33860932
- DOI: 10.1111/ajd.13595
Diagnostic tools used for melanoma: A survey of Australian general practitioners and dermatologists
Abstract
Background/objective: Diagnostic tools such as dermoscopy, sequential digital dermoscopy imaging (SDDI), total body photography (TBP) and automated diagnostic tools are available to assist in early melanoma diagnosis. The use, accessibility and barriers of dermoscopy have been well studied; however, there are few similar studies regarding SDDI, TBP and automated diagnostic tools. We aim to understand the use of these diagnostic aids amongst Australian general practitioners (GPs) and dermatologists.
Methods: Between June 2019 and January 2020, GPs and dermatologists across Australia were invited to participate in an online survey. Surveys were distributed through GP and dermatology organisations.
Results: A total of 227 survey responses were received, 175 from GPs and 52 from dermatologists. Amongst GPs, 44.6% worked in a skin cancer clinic. Dermoscopy was used at least occasionally by 98.9% of all GPs. SDDI was used by 93.6% of skin cancer GPs, 80.8% of dermatologists and 45.3% of generalist GPs. TBP was used or recommended by 77.1% of generalist GPs, 82.3% of skin cancer GPs and 86.5% of dermatologists. The most common barriers to the use of TBP were cost, limited accessibility, poor patient compliance, and time required for both patients and doctors. Very few clinicians reported using automated diagnostic tools. There was an interest in future diagnostic aids for melanoma in 88% of GPs and dermatologists.
Conclusion: Dermoscopy, SDDI and TBP were commonly used by responding Australian skin cancer GPs and dermatologists in this survey. Automated diagnostic tools were not reported to be used routinely. Several barriers were identified for use of TBP.
Keywords: dermatologists; diagnostic; general practitioners; high risk; melanoma; skin cancer; total body photography.
© 2021 The Australasian College of Dermatologists.
Similar articles
-
Practice Gaps in Dermatology: Melanocytic Lesions and Melanoma.Dermatol Clin. 2016 Jul;34(3):353-62. doi: 10.1016/j.det.2016.03.003. Dermatol Clin. 2016. PMID: 27363893 Review.
-
Dermoscopy use in UK primary care: a survey of GPs with a special interest in dermatology.J Eur Acad Dermatol Venereol. 2019 Sep;33(9):1706-1712. doi: 10.1111/jdv.15614. Epub 2019 May 17. J Eur Acad Dermatol Venereol. 2019. PMID: 30977937 Free PMC article.
-
Detection of primary melanoma in individuals at extreme high risk: a prospective 5-year follow-up study.JAMA Dermatol. 2014 Aug;150(8):819-27. doi: 10.1001/jamadermatol.2014.514. JAMA Dermatol. 2014. PMID: 24964862
-
Evaluation of dynamic dermoscopic features of melanoma and benign naevi by sequential digital dermoscopic imaging and total body photography in a high-risk Australian cohort.Australas J Dermatol. 2023 Feb;64(1):67-79. doi: 10.1111/ajd.13975. Epub 2023 Jan 18. Australas J Dermatol. 2023. PMID: 36652275
-
Skin Cancer Diagnosis by Lesion, Physician, and Examination Type: A Systematic Review and Meta-Analysis.JAMA Dermatol. 2025 Feb 1;161(2):135-146. doi: 10.1001/jamadermatol.2024.4382. JAMA Dermatol. 2025. PMID: 39535756
Cited by
-
3D Total-Body Photography in Patients at High Risk for Melanoma: A Randomized Clinical Trial.JAMA Dermatol. 2025 May 1;161(5):472-481. doi: 10.1001/jamadermatol.2025.0211. JAMA Dermatol. 2025. PMID: 40136310 Clinical Trial.
-
Use of Dermoscopy among Greek Dermatologists in Everyday Clinical Practice: A National Questionnaire-Based Study.J Clin Med. 2024 Feb 8;13(4):972. doi: 10.3390/jcm13040972. J Clin Med. 2024. PMID: 38398285 Free PMC article.
-
Melanoma Detection by Non-Specialists: An Untapped Potential for Triage?Diagnostics (Basel). 2022 Nov 16;12(11):2821. doi: 10.3390/diagnostics12112821. Diagnostics (Basel). 2022. PMID: 36428881 Free PMC article.
References
-
- Bray F, Ferlay J, Soerjomataram I et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018; 68: 394-424.
-
- Olsen CM, Green AC, Pandeya N et al. Trends in Melanoma incidence rates in eight susceptible populations through 2015. J. Invest. Dermatol. 2019; 139: 1392-5. https://doi.org/10.1016/j.jid.2018.12.006.
-
- Cancer data in Australia Canberra: Australian Institute of Health Welfare; 2019. Available from: https://www.aihw.gov.au/reports/cancer/cancer-data-in-australia, Accessed on [15/06/2020].
-
- Vallejo-Torres L, Morris S, Kinge JM et al. Measuring current and future cost of skin cancer in England. J. Public Health. 2013; 36: 140-8. https://doi.org/10.1093/pubmed/fdt032.
-
- Elliott TM, Whiteman DC, Olsen CM et al. Estimated healthcare costs of Melanoma in Australia over 3 years post-diagnosis. Appl. Health Econ. Health Policy. 2017; 15: 805-16. https://doi.org/10.1007/s40258-017-0341-y.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical